Use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population

A. Schuchat, C. V. Broome, A. Hightower, S. J. Costa and W. Parkin
Meningitis and Special Pathogens Branch, Centers for Disease Control, Atlanta, GA 30333.

We used population-based surveillance in New Jersey in 1986 to quantify the risk of invasive pneumococcal disease in persons with the acquired immunodeficiency syndrome (AIDS) and in those who went on to develop AIDS. Using pneumococcal surveillance, we also devised a method to estimate the size of the immunosuppressed population infected with the human immunodeficiency virus (HIV), the so-called pre-AIDS population. From rates of pneumococcal disease that occurred in areas with a low incidence of AIDS, we calculated the number of patients expected to contract pneumococcal disease in areas with a high incidence of AIDS. There were 59 more cases of pneumococcal disease observed than expected; 14 of these patients had AIDS by the time of pneumococcal infection. We attributed the remaining 45 cases to the increased risk of pneumococcal infection in pre-AIDS. The pre-AIDS pneumococcal cases and the attack rate of pneumococcal disease in pre-AIDS were used to estimate the size of the 1986 pre-AIDS New Jersey population as 8823 pre-AIDS cases (95% confidence interval, 7377 to 10,714) or 0.37% of the adult New Jersey population. Surveillance for marker diseases may provide a simple, independent method of estimating the pre-AIDS population.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Changes in Invasive Pneumococcal Disease among HIV-Infected Adults Living in the Era of Childhood Pneumococcal Immunization
Flannery et al.
ANN INTERN MED 2006;144:1-9.
ABSTRACT | FULL TEXT  

Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998: Opportunities for Prevention in the Conjugate Vaccine Era
Robinson et al.
JAMA 2001;285:1729-1735.
ABSTRACT | FULL TEXT  

Infections in AIDS: Proceedings of the Sixth Liverpool Tropical School Bayer Symposium on Microbial Diseases held on 6 February 1999
HART et al.
J Med Microbiol 2000;49:947-967.
FULL TEXT  

Evaluation of Effectiveness of the 23-Valent Pneumococcal Capsular Polysaccharide Vaccine for HIV-Infected Patients
Breiman et al.
Arch Intern Med 2000;160:2633-2638.
ABSTRACT | FULL TEXT  

Epidemiologic Relation between HIV and Invasive Pneumococcal Disease in San Francisco County, California
Nuorti et al.
ANN INTERN MED 2000;132:182-190.
ABSTRACT | FULL TEXT  

Invasive Pneumococcal Infection in Baltimore, Md: Implications for Immunization Policy
Harrison et al.
Arch Intern Med 2000;160:89-94.
ABSTRACT | FULL TEXT  

Depressed Phagocytosis and Oxidative Burst in Polymorphonuclear Leukocytes from Individuals with Pulmonary Tuberculosis with or without Human Immunodeficiency Virus Type 1 Infection
Shalekoff et al.
CVI 1998;5:41-44.
ABSTRACT | FULL TEXT